Halobetasol | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Halobetasol
Health Canada Patents

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-1-m-2025-11-03

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

pharmacompass-2-m-2025-11-03

Halobetasol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 7 USDMF, 5 EU WC, 5 NDC API, 21 Listed Suppliers, $ API Reference Price

26 API Suppliers
7 USDMF
5 EU WC
5 NDC API
21 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

FINISHED DOSAGE FORMULATIONS

27 FDF Dossiers, 21 FDA Orange Book, 4 Canada, 2 Listed Dossiers

27 FDF Dossiers
21 FDA Orange Book
4 Canada
2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, FOAM;TOPICAL - 0.05%

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
OINTMENT;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
AEROSOL, FOAM;TOPICAL - 0.05%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 DKSH, 3 Nanjing Well Pharmaceutical, 2 Actylis, 6 BASF, 2 Corel Pharma Chem, 1 Esteem Industries, 1 Finar, 1 Gangwal Chemicals, 2 Lubrizol Life Science Health, 1 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 1 Valens Pharmachem

2 EUROAPI
1 DKSH
3 Nanjing Well Pharmaceutical
2 Actylis
6 BASF
2 Corel Pharma Chem
1 Esteem Industries
1 Finar
1 Gangwal Chemicals
2 Lubrizol Life Science Health
1 Microlex e.U
1 Nanjing Bold Chemical
1 Pluviaendo
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

15 Topical, 7 Solubilizers, 6 Parenteral, 6 Thickeners and Stabilizers, 3 Film Formers & Plasticizers, 3 Emulsifying Agents, 2 Lubricants & Glidants, 2 Granulation, 2 Direct Compression, 1 Fillers, Diluents & Binders, 1 Surfactant & Foaming Agents, 1 Chewable & Orodispersible Aids

15 Topical
7 Solubilizers
6 Parenteral
6 Thickeners and Stabilizers
3 Film Formers & Plasticizers
3 Emulsifying Agents
2 Lubricants & Glidants
2 Granulation
2 Direct Compression
1 Fillers, Diluents & Binders
1 Surfactant & Foaming Agents
1 Chewable & Orodispersible Aids

DIGITAL CONTENT

27 News #PharmaBuzz

27 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 6 Regulatory FDF Prices

12 US Medicaid Prescriptions
6 Regulatory FDF Prices

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

20 US Patents, 3 Health Canada Patents

20 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

$ API Ref.Price (USD/KG) : 14,284 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Bausch Health, Canada Inc.

filter Patent Reset all filters

3 All

01 12417646

02 22817524

filter Product Reset all filters

3 All

01 2HALOBETASOL PROPIONATE

02 1HALOBETASOL PROPIONATE | TAZAROTENE

filter Dosage Reset all filters

3 All

01 3LOTION

filter Exp Date Reset all filters

3 All

01 12021-07-24

02 22031-11-09

Product Main Page

01

Bausch Health, Canada Inc.

HALOBETASOL PROPIONATE, TAZAROTENE

AIChE Annual Meeting

Not Confirmed

Bausch Health, Canada Inc.

Country

AIChE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-11-09

Date Granted : 2019-11-05

HALOBETASOL PROPIONATE, TAZAROTENE

Brand Name : DUOBRII

Patent Number : 2817524

Filing Date : 2011-11-09

Strength per Unit : 0.01% w / w ; 0.045% w / w

Dosage Form : LOTION

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2031-11-09

Date Granted : 2019-11-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Bausch Health, Canada Inc.

HALOBETASOL PROPIONATE

AIChE Annual Meeting

Not Confirmed

Bausch Health, Canada Inc.

Country

AIChE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-07-24

Date Granted : 2010-05-04

HALOBETASOL PROPIONATE

Brand Name : BRYHALI

Patent Number : 2417646

Filing Date : 2001-07-24

Strength per Unit : 0.01%

Dosage Form : LOTION

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2021-07-24

Date Granted : 2010-05-04

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Bausch Health, Canada Inc.

HALOBETASOL PROPIONATE

AIChE Annual Meeting

Not Confirmed

Bausch Health, Canada Inc.

Country

AIChE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-11-09

Date Granted : 2019-11-05

HALOBETASOL PROPIONATE

Brand Name : BRYHALI

Patent Number : 2817524

Filing Date : 2011-11-09

Strength per Unit : 0.01%

Dosage Form : LOTION

Human Or VET : Human

Route of Administration : TOPICAL

Patent Expiration Date : 2031-11-09

Date Granted : 2019-11-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!